| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4167858 | The Journal of Pediatrics | 2007 | 10 Pages |
Abstract
Our study suggests that preventing RSV LRTI with palivizumab may reduce subsequent recurrent wheezing in premature infants.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
Eric A.F. MB, BS, DCH, MD, Jessie R. MD, Xavier MD, PhD, Christian H.L. MD, Ian MA, MB, ChB, Linda M. MS, Jan L.L. MD, PhD, Palivizumab Long-Term Respiratory Outcomes Study Group Palivizumab Long-Term Respiratory Outcomes Study Group,